| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 9.519 | 42.987 | 9.675 | 34.822 | 22.540 | 28.986 | 27.983 | 14.480 | 0 |
| Total Income - EUR | - | 9.607 | 43.014 | 9.675 | 34.836 | 22.556 | 29.449 | 28.223 | 14.582 | 7 |
| Total Expenses - EUR | - | 87 | 825 | 9.896 | 1.040 | 4.552 | 8.603 | 5.044 | 4.715 | 6.808 |
| Gross Profit/Loss - EUR | - | 9.519 | 42.189 | -221 | 33.796 | 18.005 | 20.846 | 23.179 | 9.867 | -6.801 |
| Net Profit/Loss - EUR | - | 9.234 | 41.759 | -511 | 32.751 | 17.355 | 19.963 | 22.340 | 8.288 | -6.801 |
| Employees | - | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Lialpo Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 9.564 | 41.857 | 3.414 | 23.194 | 17.639 | 28.114 | 22.492 | 12.776 | 431 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 94 | 0 | 0 | 10.259 | 0 | 18.963 | 7.829 | 0 |
| Cash | - | 9.564 | 41.762 | 3.414 | 23.194 | 7.381 | 28.114 | 3.529 | 4.948 | 431 |
| Shareholders Funds | - | 9.234 | 41.759 | -468 | 21.270 | 17.255 | 19.865 | 22.388 | 11.703 | 48 |
| Social Capital | - | 0 | 0 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 330 | 98 | 3.883 | 1.924 | 384 | 8.249 | 104 | 1.073 | 383 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Lialpo Intermed Srl